Navigation Links
New Inspirational Memoir Aims to Support Individuals Battling Depression
Date:9/10/2012

POUGHKEEPSIE, N.Y., Sept. 10, 2012 /PRNewswire/ -- A new book released today chronicles one woman's 30-year battle with major depression and sheds light on how a novel, non-drug therapy saved her life. 3,000 Pulses intimately documents 62-year-old Martha Rhodes' nearly lifelong journey with depression and gives a harrowing yet inspirational account of how it is possible to reclaim your life from the powerful grip of mental illness and attempted suicide.

"I wrote this book to help the millions of people who are suffering from depression realize that they are not alone and there is help out there," said Rhodes. "For me, transcranial magnetic stimulation, or TMS, made all the difference and my wish is that 3,000 Pulses provides others with a beacon of hope that they, too, can find peace."

Rhodes, a former New York advertising executive who seemingly had it all, experienced depressive symptoms as a teenager but wasn't officially diagnosed with major depressive disorder until her late thirties. Rhodes took antidepressant medications for about fifteen years, but over time, the medications stopped working or the side effects became intolerable. Similar to Rhodes, an estimated 4 million people in the U.S. do not benefit from standard treatments for depression, even after repeated treatment attempts. Before Rhodes found relief with TMS, she was at a point in her life where she felt nothing mattered and was ready to give up.

The title 3,000 Pulses is based on the number of highly-focused, magnetic pulses delivered during a typical TMS treatment session to stimulate function in targeted regions of the brain thought to control mood. The book is now available for purchase at www.3000pulses.com.

Rhodes co-authored 3,000 Pulses with Dr. Randy Pardell, MD, DFAPA, Director of Riverview Psychiatric Medicine, who has witnessed firsthand the positive impact of TMS on his patients' lives.

"I have patients who suffered from severe depression for years and experienced remarkable improvements following TMS therapy after little or no response to other antidepressant medications," Pardell said. "I hope that in reading Martha's story, others living with depression will be encouraged to explore new options to treat their symptoms."

About Transcranial Magnetic Stimulation
TMS is a noninvasive, non-systemic therapeutic device that uses short pulses of a magnetic field to stimulate nerve cells in the area of the brain thought to control mood. This pulsed magnetic field may have a positive effect on the brain's neurotransmitters' levels. When used as an antidepressant therapy, TMS produces a clinical benefit without the systemic side effects typical with oral medications and has no adverse effects on cognition as occurs with electroconvulsive therapy. NeuroStar TMS Therapy® is an FDA-cleared non-drug therapy for patients with depression who have not benefitted from one prior antidepressant medication. TMS Therapy is available by prescription only and delivered under the supervision of a psychiatrist. To learn more visit: www.neurostar.com.

About Depression
Depression is a serious illness that affects about 20 million Americans annually. People with depression may experience a range of physically and emotionally debilitating symptoms, including anxiousness, sadness, irritability, fatigue, changes in sleep patterns, loss of interest in previously enjoyable activities and digestive problems. Each year in the U.S., more than 30,000 people die by suicide, 60 percent of whom suffer from depression.


'/>"/>
SOURCE TMS
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pharma Industry Stretching Every Dollar: New Study Finds Rise in Outsourcing of Key Support Functions
2. FDA Advisory Committee supports use of tobramycin inhalation powder from Novartis for patients with cystic fibrosis
3. Novation Supports New Development in the U.S. Biosimilar Pharmaceuticals Market
4. Henry Schein Cares Disaster Relief Hotline is Active and Ready to Support Customers Affected by Hurricane Isaac
5. National Call-to-Action to Boost Meningitis Vaccination Rates Supported by Leading Health Organizations, Urges Minneapolis-St. Paul Parents to Vaccinate Preteens and Teens
6. Patient Advocate Foundation Receives Significant Support to Aid Non-Squamous Non-Small Cell Lung Cancer Patients through the Co-Pay Relief Program
7. Indegene Introduces TrialPedia 2.0 with Advantage Insights, Making It the Most Comprehensive Clinical Trial Analytics and Decision Support Platform for the Pharma Industry
8. National Call-to-Action to Boost Meningitis Vaccination Rates Supported by Leading Health Organizations, Urges Nashville Parents to Vaccinate Preteens and Teens
9. Varian Medical Systems to Support an NCI-Sponsored Phase III Study Comparing Radiosurgery with Surgery for the Treatment of Early-Stage High-Risk, Operable Non-Small Cell Lung Cancer
10. National Call-to-Action to Boost Meningitis Vaccination Rates Supported by Leading Health Organizations, Urges St. Louis Parents to Vaccinate Preteens and Teens
11. USPIs Physician Strategy Group Partners with Provista to Support their Affiliated Physician Practices
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... , Oct. 4, 2017 ... single-use, self-contained, illuminating medical devices, today announced regulatory ... Health Surveillance Agency (or Agência Nacional de Vigilância ... first single-use, cordless surgical retractor with integrated LED ... optimal access, illumination and exposure of a tissue ...
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, the ... by Walgreens and pharmacy benefit manager Prime Therapeutics LLC ... brand, which included the unveiling of new signage at ... as well as at a few other company-owned facilities ... brand to patients, some of whom will begin to ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... October 13, 2017 , ... ... alumni Hannah Randall, PharmD ‘17, and Jennifer Huggins, PharmD ’17, along with ... for the primary prevention of cardiovascular diseases during the 15th Annual Women’s ...
(Date:10/13/2017)... NY (PRWEB) , ... October 13, 2017 , ... Ellevate ... people in business to advocate for action towards gender equality at their inaugural Summit ... from around the globe, and reached a social audience of over 3 million. To ...
(Date:10/13/2017)... ... , ... “The Journey: From the Mountains to the Mission Field”: the story ... the Philippines. “The Journey: From the Mountains to the Mission Field” is the creation ... has taught all ages and currently teaches a class of ladies at her church, ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... meet the demand of today’s consumer and regulatory authorities worldwide. From Children’s to ... and tested to meet the highest standard. , These products are also: ...
(Date:10/12/2017)... ... 12, 2017 , ... Dr. Parsa Mohebi, the Los Angeles ... to the newly revamped Cosmetic Town journal section, featuring articles written ... known as Follicular Unit Extraction (FUE). , Dr. Mohebi says “I ...
Breaking Medicine News(10 mins):